New Zealand markets closed

Galectin Therapeutics Inc. (GALT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2300+0.0900 (+2.87%)
At close: 04:00PM EDT
3.2700 +0.04 (+1.24%)
After hours: 04:56PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.16-0.17-0.66-1.59
Low estimate-0.16-0.17-0.66-1.59
High estimate-0.16-0.17-0.66-1.59
Year ago EPS-0.15-0.24-0.74-0.66
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/A36.32M
Low estimateN/AN/AN/A36.32M
High estimateN/AN/AN/A36.32M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.21-0.16-0.16-0.16
Actual EPS-0.15-0.24-0.16-0.19
Difference0.06-0.080-0.03
Surprise %28.60%-50.00%0.00%-18.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.16-0.17-0.66-1.59
7 days ago-0.16-0.17-0.66-1.59
30 days ago-0.16-0.17-0.66-1.59
60 days ago-0.16-0.17-0.66-1.37
90 days ago-0.16-0.17-0.66-1.37
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesGALTIndustrySector(s)S&P 500
Current qtr.-6.70%N/AN/AN/A
Next qtr.29.20%N/AN/AN/A
Current year10.80%N/AN/AN/A
Next year-140.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A